| Name | N2-{4-[(3-Fluorobenzyl)oxy]benzyl}-D-alaninamide |
|---|---|
| Synonyms |
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
FCE 28073, 10 mM in DMSO (R)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide methanesulfonate Safinamide impurity 7/(R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide (R)-Safinamide Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2R) (R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide (R)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide/Safinamide impurity 2-hydroxy-N-propylnorapomorphine hydrobromide Safinamide (R)-Isomer Safinamide-2 |
| Molecular Formula | C17H19FN2O2 |
|---|---|
| Molecular Weight | 302.34300 |
| Exact Mass | 302.14300 |
| PSA | 65.34000 |
| LogP | 3.90870 |
| Storage condition | 2-8°C |
|
~88%
174756-44-6 |
| Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 66 ; |
|
~%
174756-44-6 |
| Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 71-72 ; |
|
~%
174756-44-6 |
| Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 64-65 ; |
|
~%
174756-44-6 |
| Literature: Leonetti, Francesco; Capaldi, Carmelida; Pisani, Leonardo; Nicolotti, Orazio; Muncipinto, Giovanni; Stefanachi, Angela; Cellamare, Saverio; Caccia, Carla; Carotti, Angelo Journal of Medicinal Chemistry, 2007 , vol. 50, # 20 p. 4909 - 4916 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |